Global mRNA Drug Market Growth 2026-2032
The global mRNA Drug market size is predicted to grow from US$ 438 million in 2025 to US$ 620 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?mRNA Drug Industry Forecast? looks at past sales and reviews total world mRNA Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected mRNA Drug sales for 2026 through 2032. With mRNA Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Drug industry.
This Insight Report provides a comprehensive analysis of the global mRNA Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global mRNA Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?mRNA Drug Industry Forecast? looks at past sales and reviews total world mRNA Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected mRNA Drug sales for 2026 through 2032. With mRNA Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Drug industry.
This Insight Report provides a comprehensive analysis of the global mRNA Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global mRNA Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Preventive Vaccines
- Therapeutic Vaccine
- Therapeutic Drugs
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna
- Pfizer
- Zydus Cadila
- Fosun Pharma
- CureVAC
- Sri Lankan Microorganisms
- BioNtech
- AstraZeneca
- Janssen
- What is the 10-year outlook for the global mRNA Drug market?
- What factors are driving mRNA Drug market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do mRNA Drug market opportunities vary by end market size?
- How does mRNA Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for mRNA Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for mRNA Drug by Country/Region, 2021, 2025 & 2032
2.2 mRNA Drug Segment by Type
2.2.1 Preventive Vaccines
2.2.2 Therapeutic Vaccine
2.2.3 Therapeutic Drugs
2.2.4 mRNA Drug Sales by Type
2.2.4.1 Global mRNA Drug Sales Market Share by Type (2021-2026)
2.2.4.2 Global mRNA Drug Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global mRNA Drug Sale Price by Type (2021-2026)
2.3 mRNA Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 mRNA Drug Sales by Application
2.3.3.1 Global mRNA Drug Sale Market Share by Application (2021-2026)
2.3.3.2 Global mRNA Drug Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global mRNA Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global mRNA Drug Breakdown Data by Company
3.1.1 Global mRNA Drug Annual Sales by Company (2021-2026)
3.1.2 Global mRNA Drug Sales Market Share by Company (2021-2026)
3.2 Global mRNA Drug Annual Revenue by Company (2021-2026)
3.2.1 Global mRNA Drug Revenue by Company (2021-2026)
3.2.2 Global mRNA Drug Revenue Market Share by Company (2021-2026)
3.3 Global mRNA Drug Sale Price by Company
3.4 Key Manufacturers mRNA Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Drug Product Location Distribution
3.4.2 Players mRNA Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA DRUG BY GEOGRAPHIC REGION
4.1 World Historic mRNA Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global mRNA Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global mRNA Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic mRNA Drug Market Size by Country/Region (2021-2026)
4.2.1 Global mRNA Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global mRNA Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas mRNA Drug Sales Growth
4.4 APAC mRNA Drug Sales Growth
4.5 Europe mRNA Drug Sales Growth
4.6 Middle East & Africa mRNA Drug Sales Growth
5 AMERICAS
5.1 Americas mRNA Drug Sales by Country
5.1.1 Americas mRNA Drug Sales by Country (2021-2026)
5.1.2 Americas mRNA Drug Revenue by Country (2021-2026)
5.2 Americas mRNA Drug Sales by Type (2021-2026)
5.3 Americas mRNA Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Drug Sales by Region
6.1.1 APAC mRNA Drug Sales by Region (2021-2026)
6.1.2 APAC mRNA Drug Revenue by Region (2021-2026)
6.2 APAC mRNA Drug Sales by Type (2021-2026)
6.3 APAC mRNA Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Drug by Country
7.1.1 Europe mRNA Drug Sales by Country (2021-2026)
7.1.2 Europe mRNA Drug Revenue by Country (2021-2026)
7.2 Europe mRNA Drug Sales by Type (2021-2026)
7.3 Europe mRNA Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Drug by Country
8.1.1 Middle East & Africa mRNA Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa mRNA Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa mRNA Drug Sales by Type (2021-2026)
8.3 Middle East & Africa mRNA Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Drug
10.3 Manufacturing Process Analysis of mRNA Drug
10.4 Industry Chain Structure of mRNA Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Drug Distributors
11.3 mRNA Drug Customer
12 WORLD FORECAST REVIEW FOR MRNA DRUG BY GEOGRAPHIC REGION
12.1 Global mRNA Drug Market Size Forecast by Region
12.1.1 Global mRNA Drug Forecast by Region (2027-2032)
12.1.2 Global mRNA Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global mRNA Drug Forecast by Type (2027-2032)
12.7 Global mRNA Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna mRNA Drug Product Portfolios and Specifications
13.1.3 Moderna mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer mRNA Drug Product Portfolios and Specifications
13.2.3 Pfizer mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Information
13.3.2 Zydus Cadila mRNA Drug Product Portfolios and Specifications
13.3.3 Zydus Cadila mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Zydus Cadila Main Business Overview
13.3.5 Zydus Cadila Latest Developments
13.4 Fosun Pharma
13.4.1 Fosun Pharma Company Information
13.4.2 Fosun Pharma mRNA Drug Product Portfolios and Specifications
13.4.3 Fosun Pharma mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fosun Pharma Main Business Overview
13.4.5 Fosun Pharma Latest Developments
13.5 CureVAC
13.5.1 CureVAC Company Information
13.5.2 CureVAC mRNA Drug Product Portfolios and Specifications
13.5.3 CureVAC mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CureVAC Main Business Overview
13.5.5 CureVAC Latest Developments
13.6 Sri Lankan Microorganisms
13.6.1 Sri Lankan Microorganisms Company Information
13.6.2 Sri Lankan Microorganisms mRNA Drug Product Portfolios and Specifications
13.6.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sri Lankan Microorganisms Main Business Overview
13.6.5 Sri Lankan Microorganisms Latest Developments
13.7 BioNtech
13.7.1 BioNtech Company Information
13.7.2 BioNtech mRNA Drug Product Portfolios and Specifications
13.7.3 BioNtech mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BioNtech Main Business Overview
13.7.5 BioNtech Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca mRNA Drug Product Portfolios and Specifications
13.8.3 AstraZeneca mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Janssen
13.9.1 Janssen Company Information
13.9.2 Janssen mRNA Drug Product Portfolios and Specifications
13.9.3 Janssen mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Janssen Main Business Overview
13.9.5 Janssen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for mRNA Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for mRNA Drug by Country/Region, 2021, 2025 & 2032
2.2 mRNA Drug Segment by Type
2.2.1 Preventive Vaccines
2.2.2 Therapeutic Vaccine
2.2.3 Therapeutic Drugs
2.2.4 mRNA Drug Sales by Type
2.2.4.1 Global mRNA Drug Sales Market Share by Type (2021-2026)
2.2.4.2 Global mRNA Drug Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global mRNA Drug Sale Price by Type (2021-2026)
2.3 mRNA Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 mRNA Drug Sales by Application
2.3.3.1 Global mRNA Drug Sale Market Share by Application (2021-2026)
2.3.3.2 Global mRNA Drug Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global mRNA Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global mRNA Drug Breakdown Data by Company
3.1.1 Global mRNA Drug Annual Sales by Company (2021-2026)
3.1.2 Global mRNA Drug Sales Market Share by Company (2021-2026)
3.2 Global mRNA Drug Annual Revenue by Company (2021-2026)
3.2.1 Global mRNA Drug Revenue by Company (2021-2026)
3.2.2 Global mRNA Drug Revenue Market Share by Company (2021-2026)
3.3 Global mRNA Drug Sale Price by Company
3.4 Key Manufacturers mRNA Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Drug Product Location Distribution
3.4.2 Players mRNA Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA DRUG BY GEOGRAPHIC REGION
4.1 World Historic mRNA Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global mRNA Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global mRNA Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic mRNA Drug Market Size by Country/Region (2021-2026)
4.2.1 Global mRNA Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global mRNA Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas mRNA Drug Sales Growth
4.4 APAC mRNA Drug Sales Growth
4.5 Europe mRNA Drug Sales Growth
4.6 Middle East & Africa mRNA Drug Sales Growth
5 AMERICAS
5.1 Americas mRNA Drug Sales by Country
5.1.1 Americas mRNA Drug Sales by Country (2021-2026)
5.1.2 Americas mRNA Drug Revenue by Country (2021-2026)
5.2 Americas mRNA Drug Sales by Type (2021-2026)
5.3 Americas mRNA Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Drug Sales by Region
6.1.1 APAC mRNA Drug Sales by Region (2021-2026)
6.1.2 APAC mRNA Drug Revenue by Region (2021-2026)
6.2 APAC mRNA Drug Sales by Type (2021-2026)
6.3 APAC mRNA Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Drug by Country
7.1.1 Europe mRNA Drug Sales by Country (2021-2026)
7.1.2 Europe mRNA Drug Revenue by Country (2021-2026)
7.2 Europe mRNA Drug Sales by Type (2021-2026)
7.3 Europe mRNA Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Drug by Country
8.1.1 Middle East & Africa mRNA Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa mRNA Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa mRNA Drug Sales by Type (2021-2026)
8.3 Middle East & Africa mRNA Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Drug
10.3 Manufacturing Process Analysis of mRNA Drug
10.4 Industry Chain Structure of mRNA Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Drug Distributors
11.3 mRNA Drug Customer
12 WORLD FORECAST REVIEW FOR MRNA DRUG BY GEOGRAPHIC REGION
12.1 Global mRNA Drug Market Size Forecast by Region
12.1.1 Global mRNA Drug Forecast by Region (2027-2032)
12.1.2 Global mRNA Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global mRNA Drug Forecast by Type (2027-2032)
12.7 Global mRNA Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna mRNA Drug Product Portfolios and Specifications
13.1.3 Moderna mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer mRNA Drug Product Portfolios and Specifications
13.2.3 Pfizer mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Information
13.3.2 Zydus Cadila mRNA Drug Product Portfolios and Specifications
13.3.3 Zydus Cadila mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Zydus Cadila Main Business Overview
13.3.5 Zydus Cadila Latest Developments
13.4 Fosun Pharma
13.4.1 Fosun Pharma Company Information
13.4.2 Fosun Pharma mRNA Drug Product Portfolios and Specifications
13.4.3 Fosun Pharma mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fosun Pharma Main Business Overview
13.4.5 Fosun Pharma Latest Developments
13.5 CureVAC
13.5.1 CureVAC Company Information
13.5.2 CureVAC mRNA Drug Product Portfolios and Specifications
13.5.3 CureVAC mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CureVAC Main Business Overview
13.5.5 CureVAC Latest Developments
13.6 Sri Lankan Microorganisms
13.6.1 Sri Lankan Microorganisms Company Information
13.6.2 Sri Lankan Microorganisms mRNA Drug Product Portfolios and Specifications
13.6.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sri Lankan Microorganisms Main Business Overview
13.6.5 Sri Lankan Microorganisms Latest Developments
13.7 BioNtech
13.7.1 BioNtech Company Information
13.7.2 BioNtech mRNA Drug Product Portfolios and Specifications
13.7.3 BioNtech mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BioNtech Main Business Overview
13.7.5 BioNtech Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca mRNA Drug Product Portfolios and Specifications
13.8.3 AstraZeneca mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Janssen
13.9.1 Janssen Company Information
13.9.2 Janssen mRNA Drug Product Portfolios and Specifications
13.9.3 Janssen mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Janssen Main Business Overview
13.9.5 Janssen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. mRNA Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Preventive Vaccines
Table 4. Major Players of Therapeutic Vaccine
Table 5. Major Players of Therapeutic Drugs
Table 6. Global mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 7. Global mRNA Drug Sales Market Share by Type (2021-2026)
Table 8. Global mRNA Drug Revenue by Type (2021-2026) & ($ million)
Table 9. Global mRNA Drug Revenue Market Share by Type (2021-2026)
Table 10. Global mRNA Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global mRNA Drug Sale by Application (2021-2026) & (K Units)
Table 12. Global mRNA Drug Sale Market Share by Application (2021-2026)
Table 13. Global mRNA Drug Revenue by Application (2021-2026) & ($ million)
Table 14. Global mRNA Drug Revenue Market Share by Application (2021-2026)
Table 15. Global mRNA Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global mRNA Drug Sales by Company (2021-2026) & (K Units)
Table 17. Global mRNA Drug Sales Market Share by Company (2021-2026)
Table 18. Global mRNA Drug Revenue by Company (2021-2026) & ($ millions)
Table 19. Global mRNA Drug Revenue Market Share by Company (2021-2026)
Table 20. Global mRNA Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers mRNA Drug Producing Area Distribution and Sales Area
Table 22. Players mRNA Drug Products Offered
Table 23. mRNA Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global mRNA Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global mRNA Drug Sales Market Share Geographic Region (2021-2026)
Table 28. Global mRNA Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global mRNA Drug Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global mRNA Drug Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global mRNA Drug Sales Market Share by Country/Region (2021-2026)
Table 32. Global mRNA Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global mRNA Drug Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas mRNA Drug Sales by Country (2021-2026) & (K Units)
Table 35. Americas mRNA Drug Sales Market Share by Country (2021-2026)
Table 36. Americas mRNA Drug Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 38. Americas mRNA Drug Sales by Application (2021-2026) & (K Units)
Table 39. APAC mRNA Drug Sales by Region (2021-2026) & (K Units)
Table 40. APAC mRNA Drug Sales Market Share by Region (2021-2026)
Table 41. APAC mRNA Drug Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 43. APAC mRNA Drug Sales by Application (2021-2026) & (K Units)
Table 44. Europe mRNA Drug Sales by Country (2021-2026) & (K Units)
Table 45. Europe mRNA Drug Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 47. Europe mRNA Drug Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa mRNA Drug Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa mRNA Drug Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa mRNA Drug Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of mRNA Drug
Table 53. Key Market Challenges & Risks of mRNA Drug
Table 54. Key Industry Trends of mRNA Drug
Table 55. mRNA Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. mRNA Drug Distributors List
Table 58. mRNA Drug Customer List
Table 59. Global mRNA Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global mRNA Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas mRNA Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas mRNA Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC mRNA Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC mRNA Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe mRNA Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe mRNA Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa mRNA Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa mRNA Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global mRNA Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global mRNA Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global mRNA Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global mRNA Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Moderna Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. Moderna mRNA Drug Product Portfolios and Specifications
Table 75. Moderna mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Moderna Main Business
Table 77. Moderna Latest Developments
Table 78. Pfizer Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer mRNA Drug Product Portfolios and Specifications
Table 80. Pfizer mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Zydus Cadila Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Zydus Cadila mRNA Drug Product Portfolios and Specifications
Table 85. Zydus Cadila mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Zydus Cadila Main Business
Table 87. Zydus Cadila Latest Developments
Table 88. Fosun Pharma Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Fosun Pharma mRNA Drug Product Portfolios and Specifications
Table 90. Fosun Pharma mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Fosun Pharma Main Business
Table 92. Fosun Pharma Latest Developments
Table 93. CureVAC Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. CureVAC mRNA Drug Product Portfolios and Specifications
Table 95. CureVAC mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. CureVAC Main Business
Table 97. CureVAC Latest Developments
Table 98. Sri Lankan Microorganisms Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Sri Lankan Microorganisms mRNA Drug Product Portfolios and Specifications
Table 100. Sri Lankan Microorganisms mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Sri Lankan Microorganisms Main Business
Table 102. Sri Lankan Microorganisms Latest Developments
Table 103. BioNtech Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. BioNtech mRNA Drug Product Portfolios and Specifications
Table 105. BioNtech mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BioNtech Main Business
Table 107. BioNtech Latest Developments
Table 108. AstraZeneca Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZeneca mRNA Drug Product Portfolios and Specifications
Table 110. AstraZeneca mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Janssen Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Janssen mRNA Drug Product Portfolios and Specifications
Table 115. Janssen mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Janssen Main Business
Table 117. Janssen Latest Developments
Table 1. mRNA Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. mRNA Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Preventive Vaccines
Table 4. Major Players of Therapeutic Vaccine
Table 5. Major Players of Therapeutic Drugs
Table 6. Global mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 7. Global mRNA Drug Sales Market Share by Type (2021-2026)
Table 8. Global mRNA Drug Revenue by Type (2021-2026) & ($ million)
Table 9. Global mRNA Drug Revenue Market Share by Type (2021-2026)
Table 10. Global mRNA Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global mRNA Drug Sale by Application (2021-2026) & (K Units)
Table 12. Global mRNA Drug Sale Market Share by Application (2021-2026)
Table 13. Global mRNA Drug Revenue by Application (2021-2026) & ($ million)
Table 14. Global mRNA Drug Revenue Market Share by Application (2021-2026)
Table 15. Global mRNA Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global mRNA Drug Sales by Company (2021-2026) & (K Units)
Table 17. Global mRNA Drug Sales Market Share by Company (2021-2026)
Table 18. Global mRNA Drug Revenue by Company (2021-2026) & ($ millions)
Table 19. Global mRNA Drug Revenue Market Share by Company (2021-2026)
Table 20. Global mRNA Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers mRNA Drug Producing Area Distribution and Sales Area
Table 22. Players mRNA Drug Products Offered
Table 23. mRNA Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global mRNA Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global mRNA Drug Sales Market Share Geographic Region (2021-2026)
Table 28. Global mRNA Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global mRNA Drug Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global mRNA Drug Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global mRNA Drug Sales Market Share by Country/Region (2021-2026)
Table 32. Global mRNA Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global mRNA Drug Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas mRNA Drug Sales by Country (2021-2026) & (K Units)
Table 35. Americas mRNA Drug Sales Market Share by Country (2021-2026)
Table 36. Americas mRNA Drug Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 38. Americas mRNA Drug Sales by Application (2021-2026) & (K Units)
Table 39. APAC mRNA Drug Sales by Region (2021-2026) & (K Units)
Table 40. APAC mRNA Drug Sales Market Share by Region (2021-2026)
Table 41. APAC mRNA Drug Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 43. APAC mRNA Drug Sales by Application (2021-2026) & (K Units)
Table 44. Europe mRNA Drug Sales by Country (2021-2026) & (K Units)
Table 45. Europe mRNA Drug Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 47. Europe mRNA Drug Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa mRNA Drug Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa mRNA Drug Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa mRNA Drug Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa mRNA Drug Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of mRNA Drug
Table 53. Key Market Challenges & Risks of mRNA Drug
Table 54. Key Industry Trends of mRNA Drug
Table 55. mRNA Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. mRNA Drug Distributors List
Table 58. mRNA Drug Customer List
Table 59. Global mRNA Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global mRNA Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas mRNA Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas mRNA Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC mRNA Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC mRNA Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe mRNA Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe mRNA Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa mRNA Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa mRNA Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global mRNA Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global mRNA Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global mRNA Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global mRNA Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Moderna Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. Moderna mRNA Drug Product Portfolios and Specifications
Table 75. Moderna mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Moderna Main Business
Table 77. Moderna Latest Developments
Table 78. Pfizer Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer mRNA Drug Product Portfolios and Specifications
Table 80. Pfizer mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Zydus Cadila Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Zydus Cadila mRNA Drug Product Portfolios and Specifications
Table 85. Zydus Cadila mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Zydus Cadila Main Business
Table 87. Zydus Cadila Latest Developments
Table 88. Fosun Pharma Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Fosun Pharma mRNA Drug Product Portfolios and Specifications
Table 90. Fosun Pharma mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Fosun Pharma Main Business
Table 92. Fosun Pharma Latest Developments
Table 93. CureVAC Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. CureVAC mRNA Drug Product Portfolios and Specifications
Table 95. CureVAC mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. CureVAC Main Business
Table 97. CureVAC Latest Developments
Table 98. Sri Lankan Microorganisms Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Sri Lankan Microorganisms mRNA Drug Product Portfolios and Specifications
Table 100. Sri Lankan Microorganisms mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Sri Lankan Microorganisms Main Business
Table 102. Sri Lankan Microorganisms Latest Developments
Table 103. BioNtech Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. BioNtech mRNA Drug Product Portfolios and Specifications
Table 105. BioNtech mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BioNtech Main Business
Table 107. BioNtech Latest Developments
Table 108. AstraZeneca Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZeneca mRNA Drug Product Portfolios and Specifications
Table 110. AstraZeneca mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Janssen Basic Information, mRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Janssen mRNA Drug Product Portfolios and Specifications
Table 115. Janssen mRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Janssen Main Business
Table 117. Janssen Latest Developments
LIST OF FIGURES
Figure 1. Picture of mRNA Drug
Figure 2. mRNA Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global mRNA Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. mRNA Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. mRNA Drug Sales Market Share by Country/Region (2025)
Figure 10. mRNA Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Preventive Vaccines
Figure 12. Product Picture of Therapeutic Vaccine
Figure 13. Product Picture of Therapeutic Drugs
Figure 14. Global mRNA Drug Sales Market Share by Type in 2026
Figure 15. Global mRNA Drug Revenue Market Share by Type (2021-2026)
Figure 16. mRNA Drug Consumed in Hospital
Figure 17. Global mRNA Drug Market: Hospital (2021-2026) & (K Units)
Figure 18. mRNA Drug Consumed in Clinic
Figure 19. Global mRNA Drug Market: Clinic (2021-2026) & (K Units)
Figure 20. Global mRNA Drug Sale Market Share by Application (2025)
Figure 21. Global mRNA Drug Revenue Market Share by Application in 2026
Figure 22. mRNA Drug Sales by Company in 2026 (K Units)
Figure 23. Global mRNA Drug Sales Market Share by Company in 2026
Figure 24. mRNA Drug Revenue by Company in 2026 ($ millions)
Figure 25. Global mRNA Drug Revenue Market Share by Company in 2026
Figure 26. Global mRNA Drug Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global mRNA Drug Revenue Market Share by Geographic Region in 2026
Figure 28. Americas mRNA Drug Sales 2021-2026 (K Units)
Figure 29. Americas mRNA Drug Revenue 2021-2026 ($ millions)
Figure 30. APAC mRNA Drug Sales 2021-2026 (K Units)
Figure 31. APAC mRNA Drug Revenue 2021-2026 ($ millions)
Figure 32. Europe mRNA Drug Sales 2021-2026 (K Units)
Figure 33. Europe mRNA Drug Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa mRNA Drug Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa mRNA Drug Revenue 2021-2026 ($ millions)
Figure 36. Americas mRNA Drug Sales Market Share by Country in 2026
Figure 37. Americas mRNA Drug Revenue Market Share by Country (2021-2026)
Figure 38. Americas mRNA Drug Sales Market Share by Type (2021-2026)
Figure 39. Americas mRNA Drug Sales Market Share by Application (2021-2026)
Figure 40. United States mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC mRNA Drug Sales Market Share by Region in 2026
Figure 45. APAC mRNA Drug Revenue Market Share by Region (2021-2026)
Figure 46. APAC mRNA Drug Sales Market Share by Type (2021-2026)
Figure 47. APAC mRNA Drug Sales Market Share by Application (2021-2026)
Figure 48. China mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. India mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe mRNA Drug Sales Market Share by Country in 2026
Figure 56. Europe mRNA Drug Revenue Market Share by Country (2021-2026)
Figure 57. Europe mRNA Drug Sales Market Share by Type (2021-2026)
Figure 58. Europe mRNA Drug Sales Market Share by Application (2021-2026)
Figure 59. Germany mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. France mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. UK mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa mRNA Drug Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa mRNA Drug Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa mRNA Drug Sales Market Share by Application (2021-2026)
Figure 67. Egypt mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of mRNA Drug in 2026
Figure 73. Manufacturing Process Analysis of mRNA Drug
Figure 74. Industry Chain Structure of mRNA Drug
Figure 75. Channels of Distribution
Figure 76. Global mRNA Drug Sales Market Forecast by Region (2027-2032)
Figure 77. Global mRNA Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global mRNA Drug Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global mRNA Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global mRNA Drug Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global mRNA Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of mRNA Drug
Figure 2. mRNA Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global mRNA Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. mRNA Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. mRNA Drug Sales Market Share by Country/Region (2025)
Figure 10. mRNA Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Preventive Vaccines
Figure 12. Product Picture of Therapeutic Vaccine
Figure 13. Product Picture of Therapeutic Drugs
Figure 14. Global mRNA Drug Sales Market Share by Type in 2026
Figure 15. Global mRNA Drug Revenue Market Share by Type (2021-2026)
Figure 16. mRNA Drug Consumed in Hospital
Figure 17. Global mRNA Drug Market: Hospital (2021-2026) & (K Units)
Figure 18. mRNA Drug Consumed in Clinic
Figure 19. Global mRNA Drug Market: Clinic (2021-2026) & (K Units)
Figure 20. Global mRNA Drug Sale Market Share by Application (2025)
Figure 21. Global mRNA Drug Revenue Market Share by Application in 2026
Figure 22. mRNA Drug Sales by Company in 2026 (K Units)
Figure 23. Global mRNA Drug Sales Market Share by Company in 2026
Figure 24. mRNA Drug Revenue by Company in 2026 ($ millions)
Figure 25. Global mRNA Drug Revenue Market Share by Company in 2026
Figure 26. Global mRNA Drug Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global mRNA Drug Revenue Market Share by Geographic Region in 2026
Figure 28. Americas mRNA Drug Sales 2021-2026 (K Units)
Figure 29. Americas mRNA Drug Revenue 2021-2026 ($ millions)
Figure 30. APAC mRNA Drug Sales 2021-2026 (K Units)
Figure 31. APAC mRNA Drug Revenue 2021-2026 ($ millions)
Figure 32. Europe mRNA Drug Sales 2021-2026 (K Units)
Figure 33. Europe mRNA Drug Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa mRNA Drug Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa mRNA Drug Revenue 2021-2026 ($ millions)
Figure 36. Americas mRNA Drug Sales Market Share by Country in 2026
Figure 37. Americas mRNA Drug Revenue Market Share by Country (2021-2026)
Figure 38. Americas mRNA Drug Sales Market Share by Type (2021-2026)
Figure 39. Americas mRNA Drug Sales Market Share by Application (2021-2026)
Figure 40. United States mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC mRNA Drug Sales Market Share by Region in 2026
Figure 45. APAC mRNA Drug Revenue Market Share by Region (2021-2026)
Figure 46. APAC mRNA Drug Sales Market Share by Type (2021-2026)
Figure 47. APAC mRNA Drug Sales Market Share by Application (2021-2026)
Figure 48. China mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. India mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe mRNA Drug Sales Market Share by Country in 2026
Figure 56. Europe mRNA Drug Revenue Market Share by Country (2021-2026)
Figure 57. Europe mRNA Drug Sales Market Share by Type (2021-2026)
Figure 58. Europe mRNA Drug Sales Market Share by Application (2021-2026)
Figure 59. Germany mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. France mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. UK mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa mRNA Drug Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa mRNA Drug Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa mRNA Drug Sales Market Share by Application (2021-2026)
Figure 67. Egypt mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries mRNA Drug Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of mRNA Drug in 2026
Figure 73. Manufacturing Process Analysis of mRNA Drug
Figure 74. Industry Chain Structure of mRNA Drug
Figure 75. Channels of Distribution
Figure 76. Global mRNA Drug Sales Market Forecast by Region (2027-2032)
Figure 77. Global mRNA Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global mRNA Drug Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global mRNA Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global mRNA Drug Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global mRNA Drug Revenue Market Share Forecast by Application (2027-2032)
